As of 2:04pm ET
| -0.0049 / -0.90%|
The 1 analysts offering 12-month price forecasts for OncoGenex Pharmaceuticals Inc have a median target of 0.90, with a high estimate of 0.90 and a low estimate of 0.90. The median estimate represents a +66.64% increase from the last price of 0.54.
The current consensus among 1 polled investment analysts is to Hold stock in OncoGenex Pharmaceuticals Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.